ISCRM Faculty Shine a New Light on Scarring

Collaboration is the engine of scientific progress at UW Medicine and at the Institute of Stem Cell & Regenerative Medicine (ISCRM), where 130 researchers are developing stem cell-based approaches to treat diseases affecting nearly every organ and system in the human body. So, exactly what does it look like when two clever minds probing questions about everyday biological functioning team…
Read More
The International AIDS Vaccine Initiative announced the launch of a first-of-its-kind clinical trial Tuesday that will test a new HIV vaccine candidate. The candidate, called eOD-GT8 60mer, uses what scientists call a structure-based vaccine approach and the trial marks the first time this approach will be tested in humans. Scientists are hopeful that it could be a key step in developing…
Read More
A new five-year, $3.5 million grant from the National Cancer Institute will kick off a large clinical trial aimed at improving the quality of life and survival of medically vulnerable patients after they receive a transplant of donated blood-forming stem cells. Grantee Dr. Mohamed Sorror of Fred Hutchinson Cancer Research Center will lead the new trial. “These patients do the worst after transplant. How…
Read More
For the first time, a team of researchers has found a specific place in the human genome where variations can raise a person’s risk of erectile dysfunction. The study, Genetic variation in the SIM1 locus is associated with erectile dysfunction, was published Oct. 8 in the journal Proceedings of the National Academy of Sciences. “This study points to a new research direction for erectile…
Read More

Allen Institute Releases Data from 30,000 Brain Cells in Action

The Allen Institute for Brain Science, a division of the Allen Institute, today announced new data aimed at helping researchers understand the various types of cells in the brain and how cells compute visual information. Joining these new data is a software toolkit for building models of the neuronal networks making up the brain more easily and more reproducibly. Scientists…
Read More

Standard Myeloma Treatment Reveals Itself as an Immunotherapy

New research suggests that doctors may have had an incorrect understanding of how a standard treatment for an incurable blood cancer works to prolong lives. The therapy, based around high doses of chemotherapy or radiation, looks like it may actually be an immunotherapy — that is, a treatment that stimulates the patients’ own immune systems to help fight their cancers.…
Read More
UW Medicine researchers are exploring a potential new approach to treating the common childhood cancer acute lymphocyte  leukemia, or ALL. ALL, a blood cancer, represents approximately 25 percent of cancer diagnoses in the newborn to 15-year-old age range. More than 3,000 new cases of ALL are diagnosed every year in the United States, and the incidence is rising. Matt Hart, a postdoc  in…
Read More
Each morning, 8-year-old Erin Cross springs out of bed excited to go to school. A third grader in Chester, England, she loves science and math, and imagines a future as a researcher making “potions” in a lab. She loves cracking jokes, rugby and playing make-believe games with her friends on the playground. For Erin, who spent most of her life…
Read More
UW Medicine and Seattle Children’s announced Oct. 9 that Dr. Leslie R. Walker-Harding has been named chair of the UW School of Medicine Department of Pediatrics, associate dean for the UW School of Medicine and senior vice president/chief academic officer for Seattle Children’s. Walker-Harding will assume her new position on Feb. 15, 2019. Walker-Harding is currently a professor and chair…
Read More
Seattle researchers are addressing government concerns about viral outbreaks in the United States through the development of the flu patch. This unique method of delivering vaccinations makes healthcare more accessible to Americans and potentially people around the world. The Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that produces diagnostic tools and vaccines to solve global health challenges, was approached…
Read More